Stem Cell Network
Michael Rudnicki is a senior scientist and director at the Ottawa Hospital Research Institute, a position held since June 2000. Additionally, Michael serves as the Chief Discovery Officer at Satellos Bioscience Inc. since May 2018 and has been the scientific director and CEO of the Stem Cell Network since 2005. Prior experience includes roles as an associate professor with tenure and assistant professor at McMaster University from January 1992 to June 2000, and a postdoctoral fellow at the Whitehead Institute from April 1988 to January 1992. Michael earned a Doctor of Philosophy in Molecular Biology from the University of Ottawa between 1982 and 1988.
This person is not in any teams
Stem Cell Network
The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects and 30 clinical trials. Since its inception, over 25 biotech companies have been catalyzed or enhanced and more than 7,000 highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–2025 period. In 2023, the Government of Canada announced additional funding for SCN through the Strategic Science Fund that will support SCN to the end of the decade.